Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
Blood|October 10, 2015
Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation eventDavid M Burns, Rose Tierney, Claire Shannon-Lowe, et al.
The Lancet. Healthy Longevity|August 17, 2021
Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5-6 weeks post vaccine in participants aged 80 years or older: an exploratory analysisHelen Parry, Rachel Bruton, Gokhan Tut, et al.
Elife|June 23, 2023
Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinomaWayne Croft, Hayden Pearce, Sandra Margielewska-Davies, et al.
The Oncologist|June 17, 2025
COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion reviewIgor Aurer, Paul Moss, Michel Goldman, et al.
Disease Models & Mechanisms|September 24, 2015
T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid miceCeri E Oldreive, Anna Skowronska, Nicholas J Davies, et al.
Leukemia Research|July 6, 2019
Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid diseaseFrancesca A M Kinsella, Charlotte F Inman, Amy Gudger, et al.
Scientific Reports|May 13, 2022
Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical studyMorven Wilkie, Rachel Tanner, Daniel Wright, et al.
Vaccine|February 9, 2016
A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adultsAlice Minhinnick, Iman Satti, Stephanie Harris, et al.
The Lancet Regional Health. Europe|December 20, 2023
Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM studyRachael A Evans, Sabada Dube, Yi Lu, et al.
The Lancet Regional Health. Europe|August 19, 2024
Corrigendum to 'Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study' [The Lancet Regional Health - Europe 35 (2023) 100747]Rachael A Evans, Sabada Dube, Yi Lu, et al.
Pageof 18